Abstract
Human cDNAs encoding a novel member of Tob/BTG1 anti-proliferative family proteins were cloned. The putative protein product termed Tob2 consisted of 344 amino acids with high similarity to the Tob protein. The tob2 mRNA was 4.1 kb long and was ubiquitously expressed in human adult tissues, as was revealed by Northern blot hybridization. However, further in situ hybridization analysis showed a characteristic expression of the tob2 mRNA in oocytes, suggesting a unique role of Tob2 in oogenesis. Like the Tob protein, Tob2 inhibited cell cycle progression from the G0/G1 to S phases. Intriguingly, the amino-terminal half of Tob2 as well as that of Tob was associated with a human homologue of yeast Caf1, a component of the CCR4 transcription factor complex. Moreover, Caf1 was associated with cyclin dependent kinases. These data suggested that both Tob and Tob2 were involved in cell cycle regulation through their interaction with Caf1. Finally, the tob2 gene was mapped to human chromosome 22q13.1-q13.31.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baeg GH, Matsushime A, Kuroda T, Bhattacharjee RN, Miyashiro I, Toyoshima K and Akiyama T. . 1995 EMBO J. 14: 5618–5625.
Bogdan JA, AdamsBurton C, Pedicord DL, Sukovich DA, Benfield PA, Corjay MH, Stoltenborg JK, Dicker IB. . 1998 Biochem. J. 336: 471–481.
Bradbury A, Possenti R, Sooter EM and Tirone F. . 1991 Proc. Natl. Acad. Sci. USA 88: 3353–3357.
Denis CL. . 1984 Genetics 108: 833–844.
Denis CL and Malver T. . 1990 Genetics 124: 283–291.
Draper MP and Denis CL. . 1995 Mol. Cell. Biol. 15: 3487–3495.
Durfee T, Becherer K, Chen P-L, Yeh S-H, Yang Y, Kilburn A, Lee W-H and Elledge SJ. . 1993 Genes Dev. 7: 555–569.
Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA and Herschman HR. . 1991 J. Biol. Chem. 266: 14511–14518.
Game JC. . 1993 Semm. Cancer Biol. 4: 73–83.
Guehenneux F, Duret L, Callanan MB, Bouhas R Hayette S, Berthet C, Samaruit C, Rimokh R, Birot AM, Wang Q, Magaud JP, Rouault JP. . 1997 Leukemia 11: 370–375.
Harper JW, Adami G, Wei N, Keyomarsi K and Elledge SJ. . 1993 Cell 75: 805–816.
Hirai M, Kusuda J and Hashimoto K. . 1996 Genomics 34: 263–265.
Iida A, Kurose K, Isobe R, Akiyama F, Sakamoto G, Yoshimoto M, Kasumi F, Nakamura Y and Emi M. . 1998 Genes Chromosomes Cancer 21: 108–112.
Kim M, Tezuka T, Suziki Y, Sugano S, Hirai M and Yamamoto T. . 1999 Gene in press.
Liu H-Y, Toyn J-H, Chiang Y-C, Draper M, Johnston LH and Denis CL. . 1997 EMBO J. 16: 5289–5298.
Liu H-Y, Badarinarayana V, Andino DC, Rappsilber J, Maun M and Denis CL. . 1998 EMBO J. 17: 1096–1198.
Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, Emi M, Nakamura Y, Onda M, Yoshida Y, Nishiyama A and Yamamoto T. . 1996 Oncogene 12: 705–713.
Montagnoli A, Guardavaccaro D, Starace G and Tirone F. . 1996 Cell Growth Differ. 7: 1327–1336.
Raburn DJ, Hamil KG, Tsurata JK, Obrien DA, Hall SH. . 1995 Endocrinology 136: 5769–5777.
Rouault J-P, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garoccio M, Germain D, Samarut J and Magaud J-P. . 1992 EMBO J. 11: 1663–1670.
Rouault J-P, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C and Puisieux A. . 1996 Nature Genet. 14: 482–486.
Rouault J-P, Prevot D, Berthet C, Birot A-M, Billaud M, Magaud J-P and Corbo L. . 1998 J. Biol. Chem. 273: 22563–22569.
Schild D. . 1995 Genetics 140: 115–127.
Shiio Y, Yamamoto T and Yamaguchi N. . 1992 Proc. Natl. Acad. Sci. USA 89: 5206–5210.
Tang J, Gary JD, Clarke S and Herschman HR. . 1998 J. Biol. Chem. 273: 16935–16945.
Umemori H, Wanaka A, Kato H, Takeuchi M, Tohyama M and Yamamoto T. . 1992 Mol. Brain Res. 16: 303–310.
Walden PD, Lefkowitz GK, Ficazzola M, Gitlin J, Lepor H. . 1998 Exp. Cell Res 245: 19–26.
Yoshida Y, Matsuda S, Ikematsu N, Kawamura-Tsuzuku J, Inazawa J, Umemori H and Yamamoto T. . 1998 Oncogene 15: 2687–2693.
Acknowledgements
This work was initiated by S Matsuda. We thank S Matsuda, J Inoue, H Umemori, S Kuramochi, T Ishida, T Tezuka and M Kim for technical support and valuable discussions. We also thank S Mori and Y Morishita for technical advice and helpful discussions. We appreciate A Tanaka for critical reading of the manuscript. This work was supported in part by a grant for Advanced Cancer Research from the Ministry of Education, Science, Sports and Culture of Japan and the Program for the Promotion of Fundamental Studies in Health Science of Organization for Drug ADR Relief, R&D Promotion and Product Review of Japan.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ikematsu, N., Yoshida, Y., Kawamura-Tsuzuku, J. et al. Tob2, a novel anti-proliferative Tob/BTG1 family member, associates with a component of the CCR4 transcriptional regulatory complex capable of binding cyclin-dependent kinases. Oncogene 18, 7432–7441 (1999). https://doi.org/10.1038/sj.onc.1203193
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203193
Keywords
This article is cited by
-
MiR-5100 promotes osteogenic differentiation by targeting Tob2
Journal of Bone and Mineral Metabolism (2017)
-
Tob1 is expressed in developing and adult gonads and is associated with the P-body marker, Dcp2
Cell and Tissue Research (2016)
-
Antiproliferative protein Tob directly regulates c-myc proto-oncogene expression through cytoplasmic polyadenylation element-binding protein CPEB
Oncogene (2014)
-
hCAF1/CNOT7 regulates interferon signalling by targeting STAT1
The EMBO Journal (2013)
-
Dynamics of microRNAs in bull spermatozoa
Reproductive Biology and Endocrinology (2012)